The viable circulating tumor cells with cancer stem cells feature, where is the way out?

[1]  B. Rath,et al.  Circulating tumor cell interactions with macrophages: implications for biology and treatment. , 2017, Translational lung cancer research.

[2]  A. Czarnecka,et al.  Three‐dimensional cell culture model utilization in cancer stem cell research , 2017, Biological reviews of the Cambridge Philosophical Society.

[3]  Xiaoyan Zhang,et al.  Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications , 2017, Oncotarget.

[4]  Peng Li,et al.  Current status and perspectives of patient-derived xenograft models in cancer research , 2017, Journal of Hematology & Oncology.

[5]  Shinya Sugimoto,et al.  Visualization and targeting of LGR5+ human colon cancer stem cells , 2017, Nature.

[6]  Antonina V. Kurtova,et al.  A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer , 2017, Nature.

[7]  L. Farinelli,et al.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion , 2017, PloS one.

[8]  F. Bertucci,et al.  Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  N. Stoecklein,et al.  Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion , 2016, Oncotarget.

[10]  下川 真理子.  Visualization and targeting of LGR5⁺ human colon cancer stem cells(審査報告) , 2017 .

[11]  Z. Cai,et al.  Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells. , 2017, European urology.

[12]  J. Xu,et al.  Breast cancer stem cell: the roles and therapeutic implications , 2016, Cellular and Molecular Life Sciences.

[13]  P. Newsholme,et al.  Cancer stem cell metabolism: a potential target for cancer therapy , 2016, Molecular Cancer.

[14]  Forrest M Kievit,et al.  Culture on 3D Chitosan‐Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells , 2016, Advanced healthcare materials.

[15]  Hushan Yang,et al.  Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer , 2016, International journal of molecular sciences.

[16]  V. Budach,et al.  Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival , 2016, PloS one.

[17]  K. O'Byrne,et al.  Short term ex-vivo expansion of circulating head and neck tumour cells , 2016, Oncotarget.

[18]  N. Aceto,et al.  Recent advances in the biology of human circulating tumour cells and metastasis , 2016, ESMO Open.

[19]  G. Taylor,et al.  Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture , 2016, Gut.

[20]  Dan Xie,et al.  Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2 , 2016, Clinical Cancer Research.

[21]  C. Mignogna,et al.  Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment , 2016, Journal of Translational Medicine.

[22]  R. Matkowski,et al.  Molecular characterization of circulating tumor cells in ovarian cancer. , 2016, American journal of cancer research.

[23]  T. Schlomm,et al.  Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer. , 2016, Urologic oncology.

[24]  Jimin Liang,et al.  Cell-free circulating tumor DNA in cancer , 2016, Chinese journal of cancer.

[25]  B. Rath,et al.  Small cell lung cancer: Recruitment of macrophages by circulating tumor cells , 2016, Oncoimmunology.

[26]  K. Pantel,et al.  Functional studies on circulating and disseminated tumor cells in carcinoma patients , 2016, Molecular oncology.

[27]  S. Benitah,et al.  The epigenetics of tumour initiation: cancer stem cells and their chromatin. , 2016, Current opinion in genetics & development.

[28]  Yupei Zhao,et al.  Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance. , 2016, Medical hypotheses.

[29]  R. Ravasio,et al.  Self-renewal of tumor cells: epigenetic determinants of the cancer stem cell phenotype. , 2016, Current opinion in genetics & development.

[30]  T. Chou,et al.  Identifying cancer origin using circulating tumor cells , 2016, Cancer biology & therapy.

[31]  U. Jeschke,et al.  Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets , 2016, Journal of Cancer Research and Clinical Oncology.

[32]  Charlotte Proudhon,et al.  Circulating tumor cells in breast cancer† , 2016, Molecular oncology.

[33]  A. Rehemtulla,et al.  Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer. , 2015, Cancer research.

[34]  M. Jedryka,et al.  The added value of circulating tumor cells examination in ovarian cancer staging. , 2015, American journal of cancer research.

[35]  R. Matkowski,et al.  Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers. , 2015, American journal of translational research.

[36]  S. M. Leong,et al.  Sampling circulating tumor cells for clinical benefits: how frequent? , 2015, Journal of Hematology & Oncology.

[37]  Tuan Zea Tan,et al.  Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy , 2015, Oncotarget.

[38]  R. Matkowski,et al.  Detection and cultivation of circulating tumor cells in gastric cancer , 2015, Cytotechnology.

[39]  Udo Schumacher,et al.  Establishment and characterization of a cell line from human circulating colon cancer cells. , 2015, Cancer research.

[40]  G. Yousef,et al.  miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/tumor initiating cell properties , 2014, Oncotarget.

[41]  O. Topolcan,et al.  May CTC technologies promote better cancer management? , 2015, EPMA Journal.

[42]  Bo Lu,et al.  Separable Bilayer Microfiltration Device for Viable Label-free Enrichment of Circulating Tumour Cells , 2014, Scientific Reports.

[43]  V. Bobek,et al.  Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation. , 2014, World journal of gastroenterology.

[44]  Robert B Livingston,et al.  Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Hui Jiang,et al.  Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model , 2014, Oncotarget.

[46]  V. Bobek,et al.  Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[47]  S. Chouaib,et al.  Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment , 2014, Cancer Microenvironment.

[48]  Hans Clevers,et al.  Organoid Cultures Derived from Patients with Advanced Prostate Cancer , 2014, Cell.

[49]  R. Hoffman,et al.  In Vitro Culture and Characterization of Human Lung Cancer Circulating Tumor Cells Isolated by Size Exclusion from an Orthotopic Nude-Mouse Model Expressing Fluorescent Protein , 2014, Journal of Fluorescence.

[50]  K. Pantel,et al.  Challenges in circulating tumour cell research , 2014, Nature Reviews Cancer.

[51]  Sridhar Ramaswamy,et al.  Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility , 2014, Science.

[52]  Johan Lindberg,et al.  Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo , 2014, Breast Cancer Research.

[53]  G. Gerken,et al.  Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma , 2014, Hepatology International.

[54]  Dan Luo,et al.  Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer , 2014, BioMed research international.

[55]  Alexander R A Anderson,et al.  Bridging population and tissue scale tumor dynamics: a new paradigm for understanding differences in tumor growth and metastatic disease. , 2014, Cancer research.

[56]  J. Medema,et al.  Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame? , 2013, Cancer letters.

[57]  K. Pantel,et al.  Capture of viable circulating tumor cells in the liver of colorectal cancer patients. , 2013, Clinical chemistry.

[58]  M. Marra,et al.  A cancer stem cell model for studying brain metastases from primary lung cancer. , 2013, Journal of the National Cancer Institute.

[59]  Wei Yin,et al.  The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis , 2013, Science Translational Medicine.

[60]  M. D. Wetzel,et al.  A Correction to the Research Article Titled: "The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis" by L. Zhang, L. D. Ridgway, , 2013 .

[61]  Sridhar Ramaswamy,et al.  Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. , 2012, Cancer discovery.

[62]  E. Yagüe,et al.  Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo , 2012, Proceedings of the National Academy of Sciences.

[63]  J. Visvader,et al.  Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.

[64]  Q. Pan,et al.  Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. , 2012, Urologic oncology.

[65]  G. Mukherjee,et al.  Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties , 2012, Oncogene.

[66]  D. Richel,et al.  The developing cancer stem-cell model: clinical challenges and opportunities. , 2012, The Lancet. Oncology.

[67]  Peter Dirks,et al.  Cancer stem cells: an evolving concept , 2012, Nature Reviews Cancer.

[68]  C. Alix-Panabières.  EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. , 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[69]  Sik Yoon,et al.  Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research , 2011, Cellular and Molecular Life Sciences.

[70]  Bo Lu,et al.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood , 2011, Biomedical microdevices.

[71]  K. Struhl,et al.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion , 2011, Proceedings of the National Academy of Sciences.

[72]  J. Lowe,et al.  Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion , 2010, Neuro-oncology.

[73]  S. Jeffrey,et al.  Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype , 2010, British Journal of Cancer.

[74]  N. Habib,et al.  Unique localization of circulating tumor cells in patients with hepatic metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[76]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[77]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[78]  N. Nishiyama,et al.  3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. , 2009, Biomaterials.

[79]  G. Mukherjee,et al.  Phenotypic and Functional Characterization of Human Mammary Stem/Progenitor Cells in Long Term Culture , 2009, PloS one.

[80]  John A. Foekens,et al.  Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR , 2009, Breast Cancer Research and Treatment.

[81]  R. Weinberg,et al.  Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. , 2007, Cancer research.

[82]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[83]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[84]  Rolf Bjerkvig,et al.  The origin of the cancer stem cell: current controversies and new insights , 2005, Nature Reviews Cancer.

[85]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[86]  S. Schwartz,et al.  Prostate cancer and other xenografts from cells in peripheral blood of patients. , 2000, Cancer research.

[87]  A. Weiss,et al.  Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[88]  S. Weiss,et al.  Is there a neural stem cell in the mammalian forebrain? , 1996, Trends in Neurosciences.

[89]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[90]  Angelo L. Vescovi,et al.  bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells , 1993, Neuron.

[91]  R. H. Levin,et al.  Persistent Mitosis of Transfused Homologous Leukocytes in Children Receiving Antileukemic Therapy , 1963, Science.

[92]  P. Nowell,et al.  A minute chromosome in human chronic granulocytic leukemia , 1960 .

[93]  S H SEAL,et al.  Silicone flotation: A simple quantitative method for the isolation of free‐floating cancer cells from the blood , 1959, Cancer.